|
ERBB2IP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.090600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.632400E-01 |
| Normal-vs-Stage2 |
4.312000E-01 |
| Normal-vs-Stage3 |
7.110800E-01 |
| Normal-vs-Stage4 |
2.234400E-01 |
| Stage1-vs-Stage2 |
1.517020E-01 |
| Stage1-vs-Stage3 |
2.080200E-01 |
| Stage1-vs-Stage4 |
2.886400E-02 |
| Stage2-vs-Stage3 |
6.252400E-01 |
| Stage2-vs-Stage4 |
7.956600E-01 |
| Stage3-vs-Stage4 |
4.042200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.615000E-01 |
| Normal-vs-AfricanAmerican |
1.299580E-01 |
| Normal-vs-Asian |
6.888600E-01 |
| Caucasian-vs-AfricanAmerican |
6.691500E-02 |
| Caucasian-vs-Asian |
6.991400E-01 |
| AfricanAmerican-vs-Asian |
5.959800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.180400E-01 |
| Normal-vs-Female |
9.147800E-01 |
| Male-vs-Female |
9.882000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.646400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.616600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.689000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.883400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.398100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.574260E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.374000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.096600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.099200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.497600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.653600E-02 |
| Classical-VS-Follicular |
1.375970E-02 |
| Classical-VS-Other |
4.960000E-01 |
| Classical-VS-Normal |
3.278200E-01 |
| Tall-VS-Follicular |
9.021800E-01 |
| Tall-VS-Other |
8.022000E-01 |
| Tall-VS-Normal |
3.312600E-01 |
| Follicular-VS-Other |
8.859000E-01 |
| Follicular-VS-Normal |
3.342800E-01 |
| Other-VS-Normal |
7.530800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.280600E-01 |
| Normal-vs-N1 |
6.996600E-01 |
| N0-vs-N1 |
8.199400E-01 |
|
|
